Exhibit 99.1


Biostage Reports Second Quarter 2019 Financial Results


-        Preparing to file first IND in September 2019



Holliston, MA – August 13, 2019 –

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced its financial results for the three and six months ended June 30, 2019.


Similar to its first quarter, Biostage focused its main efforts in the second quarter on finalizing the groundwork for its planned September 2019 Investigational New Drug (IND) filing with the U.S. Food and Drug Administration (FDA). This milestone, subject to FDA approval, will mark Biostage’s transition to a clinical stage company and allow it to begin clinical trials of its groundbreaking Cellspan™ Esophageal Implant (CEI) product candidate.


Biostage has been working to meticulously prepare for these clinical trials during 2019, striving to get all the moving parts in place and up to the FDA’s rigorous quality and manufacturing standards.


Biostage CEO Jim McGorry commented that he is pleased with the Biostage team’s steady pace in fulfilling the FDA’s many requirements.


“We had a low-profile second quarter this past spring, but we’ve made great headway towards our imminent goal to file our first IND with the FDA in September. We believe our Cellspan implant has the potential to change lives, so after all the time and effort invested in this project, it’s a wonderful thing to see our clinical stage coming over the horizon. We still have a lot of due diligence and final details to work through, but the Biostage team along with our regulatory partners and consultants have been focused on reaching our goal.”


McGorry also explained that Biostage continues to bring in private placement funding at a premium to its share price in order to fund the Company.


The following information was filed by Biostage, Inc. (BSTG) on Tuesday, August 13, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Biostage, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biostage, Inc..


Never Miss A New SEC Filing Again

Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.


We Highlighted This SEC Filing For You

SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.


Widen Your SEC Filing Reading Experience

Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view


Uncover Actionable Information Inside SEC Filings

SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q


FREE Adobe PDF, Microsoft Word and Excel Downloads

Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue for FREE

Log in with your credentials


Forgot your details?

Create Account